Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Roselene Mesquita Augusto Passos, Miriam Allein Zago Marcolino, Júlia Augusto Passos, Vinicius Fernando Calsavara, Leila de Lourdes Martins Perobelli, Alessandro Gonçalves Campolina, Cesar de Almeida‐Neto |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Poor Mobilization and Plerixafor Use in Matched Related Peripheral Hematopoietic Progenitor Cell Donors
by: Elizabeth A. Godbey, et al.
Published: (2025)
by: Elizabeth A. Godbey, et al.
Published: (2025)
Preemptive Approach to Plerixafor Use Is Optimal in Patients With Relapsed/Refractory Germ Cell Tumors Undergoing Peripheral Blood Hematopoietic Stem Cell Collection: Effect on Collection Days, Yields, and Cost
by: David O. Sohutskay, et al.
Published: (2024)
by: David O. Sohutskay, et al.
Published: (2024)
Safety and Efficacy of Cyclophosphamide With Dual Mecapegfilgrastim and On‐Demand Plerixafor for Salvage Mobilization in Patients With Initial Mobilization Failure: A Retrospective Cohort
by: Fang Huang, et al.
Published: (2026)
by: Fang Huang, et al.
Published: (2026)
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project
by: Ayda Javanbakht, et al.
Published: (2024)
by: Ayda Javanbakht, et al.
Published: (2024)
G‐CSF Only Versus Chemotherapy and G‐CSF Peripheral Blood Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplant—Assessing a Change in Regime due to the COVID‐19 Pandemic
by: Julia S. Wolf, et al.
Published: (2025)
by: Julia S. Wolf, et al.
Published: (2025)
Transient Wavy Collection Trend in Hematopoietic Stem Cell Apheresis: A Rare and Underreported Occurrence
by: Dibyajyoti Sahoo, et al.
Published: (2025)
by: Dibyajyoti Sahoo, et al.
Published: (2025)
RETRACTED: Beyond Donation: Rethinking Long‐Term Support Systems for Hematopoietic Stem Cell Donors
by: RishiRaj Sinha
Published: (2025)
by: RishiRaj Sinha
Published: (2025)
RETRACTION : Beyond Donation: Rethinking Long‐Term Support Systems for Hematopoietic Stem Cell Donors
Published: (2025)
Published: (2025)
Erratum to “Transient Wavy Collection Trend in Hematopoietic Stem Cell Apheresis: A Rare and Underreported Occurrence”
Published: (2025)
Published: (2025)
Transient Wavy Collection Trend in Hematopoietic Stem Cell Apheresis: A Rare and Underreported Occurrence—Reply to Case Report
by: Jesus Fernandez‐Sojo, et al.
Published: (2025)
by: Jesus Fernandez‐Sojo, et al.
Published: (2025)
Hematopoietic Stem Cell Donors' Experiences of Information and Side‐Effects During the First Year After Donation—A Swedish National Study
by: Annika M. Kisch, et al.
Published: (2025)
by: Annika M. Kisch, et al.
Published: (2025)
Citrate Versus Citrate–Heparin Anticoagulation in HPC (A): Comparative Effects on Intra‐Apheresis Mobilization of CD34 + Hematopoietic Progenitor Cells
by: Yandy Marx Castillo‐Aleman, et al.
Published: (2026)
by: Yandy Marx Castillo‐Aleman, et al.
Published: (2026)
Chemo‐Mobilization Using Modified PACE Regimens in Multiple Myeloma Patients
by: Laura Cooling, et al.
Published: (2025)
by: Laura Cooling, et al.
Published: (2025)
Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
by: Aaron J. Wyble, et al.
Published: (2025)
by: Aaron J. Wyble, et al.
Published: (2025)
Systematic Investigation of the Location of CD34 + Cells Within the Mononuclear Cell Layer of Hematopoietic Progenitor Cell Collections in Normal Donors
by: Minlin Wu, et al.
Published: (2025)
by: Minlin Wu, et al.
Published: (2025)
Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection
by: Rajat Bansal, et al.
Published: (2025)
by: Rajat Bansal, et al.
Published: (2025)
Streamlining Apheresis: A Dual‐Intervention Quality Improvement Initiative to Increase the Efficiency in Stem Cell Collection
by: Ivy E. Verriet, et al.
Published: (2025)
by: Ivy E. Verriet, et al.
Published: (2025)
Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G‐CSF Treatment in Unrelated Donors
by: Gulten Korkmaz, et al.
Published: (2026)
by: Gulten Korkmaz, et al.
Published: (2026)
Diffusive Versus Convective Continuous Renal Replacement Therapy for Acute Kidney Injury: A Systematic Review and Meta‐Analysis
by: Fatima Masud, et al.
Published: (2026)
by: Fatima Masud, et al.
Published: (2026)
Comparison of Adverse Reactions With Solvent/Detergent Treated Plasma Versus Untreated Plasma Use in Therapeutic Plasma Exchange in Pediatric Patients
by: Samantha Phou, et al.
Published: (2025)
by: Samantha Phou, et al.
Published: (2025)
Comparison of Clinical Efficacy of Low‐Site Catheter Placement With Long‐Segment Rectus Abdominis Embedding Versus Conventional Peritoneal Dialysis Catheter Placement
by: Sha Chen, et al.
Published: (2025)
by: Sha Chen, et al.
Published: (2025)
Multiday Use of Non‐Tunneled Central Venous Catheters in Vetted Adult Outpatients Undergoing Apheresis Collections of Autologous Peripheral Blood Stem Cells Is Feasible and Well Tolerated
by: Andres E. Mindiola Romero, et al.
Published: (2026)
by: Andres E. Mindiola Romero, et al.
Published: (2026)
Post‐COVID‐19 inflammation and sarcopenia in obese diabetic dialysis patients
by: Carlos Alexandre Ferreira de Oliveira, et al.
Published: (2024)
by: Carlos Alexandre Ferreira de Oliveira, et al.
Published: (2024)
Association of neutrophil/lymphocyte and platelet/lymphocyte ratios with inflammation and survival in Mexican patients on chronic hemodialysis
by: Venice Chávez Valencia, et al.
Published: (2024)
by: Venice Chávez Valencia, et al.
Published: (2024)
A Descriptive 5‐Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021
by: Jeremy W. Jacobs, et al.
Published: (2025)
by: Jeremy W. Jacobs, et al.
Published: (2025)
Effects of Rheopheresis in dialysis patients with peripheral artery disease and diabetic foot ulcers: A multicentric Italian study
by: Claudia Altobelli, et al.
Published: (2024)
by: Claudia Altobelli, et al.
Published: (2024)
In Response to a Letter to the Editor on Our Recent Publication “Performance of Total Blood Volume Algorithms in Obesity and Severe Obesity”
by: Caitlin Raymond
Published: (2025)
by: Caitlin Raymond
Published: (2025)
Therapeutic Apheresis and Dialysis Forthcoming Events April 2026
Published: (2026)
Published: (2026)
Predicting the Future Burden of Renal Replacement Therapy in Türkiye Using National Registry Data and Comparative Modeling Approaches
by: Arzu Akgül, et al.
Published: (2026)
by: Arzu Akgül, et al.
Published: (2026)
Exploring the Immune Response to COVID ‐19 Vaccines in Dialysis and Transplant Patients
by: Hui Wen You, et al.
Published: (2025)
by: Hui Wen You, et al.
Published: (2025)
Effectiveness and safety of therapeutic plasma exchange in neurological diseases: An 11‐year report from a tertiary care center
by: Gulten Korkmaz, et al.
Published: (2024)
by: Gulten Korkmaz, et al.
Published: (2024)
Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy; Should It Be the First Choice Over Heparin in Children?
by: Guntulu Sık
Published: (2025)
by: Guntulu Sık
Published: (2025)
The Impact of Lipoprotein Apheresis on Changes in Biochemical Enzymes: A Systematic Review and Meta‐Analysis
by: Alireza Hatami, et al.
Published: (2026)
by: Alireza Hatami, et al.
Published: (2026)
Validating the Recorded Electronic Health Record ( EHR ) and Actual Weight: Single Institution Study
by: Su Yeon Yeon, et al.
Published: (2026)
by: Su Yeon Yeon, et al.
Published: (2026)
Leukapheresis for a 1.5‐Month‐Old Infant With Severe Pertussis and Hyperleukocytosis: A Case Report
by: Yixin Gao, et al.
Published: (2026)
by: Yixin Gao, et al.
Published: (2026)
Intraoperative Therapeutic Plasma Exchange for Sensitized Heart Transplant Candidates
by: Furkan Yigitbilek, et al.
Published: (2026)
by: Furkan Yigitbilek, et al.
Published: (2026)
Development of a Novel Calculation Tool for Mixed Replacement Therapy Using Fresh Frozen Plasma and Albumin for Therapeutic Plasma Exchange
by: Yosuke Imamura, et al.
Published: (2026)
by: Yosuke Imamura, et al.
Published: (2026)
Effect of intermittent hemodialysis filtration mode on intradialytic hypotension and nutritional status in patients with end‐stage renal disease
by: Meina Guo, et al.
Published: (2025)
by: Meina Guo, et al.
Published: (2025)
Nurse‐Led Apheresis Service in a Pediatric Restructured Hospital: The Past, the Present, and the Future
by: Pham Thi Ngoc Anh, et al.
Published: (2025)
by: Pham Thi Ngoc Anh, et al.
Published: (2025)
Efficiency comparison between new single‐needle dialysis and conventional double‐needle dialysis and exploration of the optimal prescription parameters for single‐needle hemodialysis
by: Bin Zhao, et al.
Published: (2025)
by: Bin Zhao, et al.
Published: (2025)
Similar Items
-
Poor Mobilization and Plerixafor Use in Matched Related Peripheral Hematopoietic Progenitor Cell Donors
by: Elizabeth A. Godbey, et al.
Published: (2025) -
Preemptive Approach to Plerixafor Use Is Optimal in Patients With Relapsed/Refractory Germ Cell Tumors Undergoing Peripheral Blood Hematopoietic Stem Cell Collection: Effect on Collection Days, Yields, and Cost
by: David O. Sohutskay, et al.
Published: (2024) -
Safety and Efficacy of Cyclophosphamide With Dual Mecapegfilgrastim and On‐Demand Plerixafor for Salvage Mobilization in Patients With Initial Mobilization Failure: A Retrospective Cohort
by: Fang Huang, et al.
Published: (2026) -
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project
by: Ayda Javanbakht, et al.
Published: (2024) -
G‐CSF Only Versus Chemotherapy and G‐CSF Peripheral Blood Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplant—Assessing a Change in Regime due to the COVID‐19 Pandemic
by: Julia S. Wolf, et al.
Published: (2025)